Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
131.73 | -10.39% | 2.75% | 333,646.57 | 2.39% | -19.03% |
|
SWX:ROG
Roche Holding
|
227.50 | 30.63% | 46.57% | 183,645.06 | 4.27% | 0.43% |
|
ENXTPA:SAN
Sanofi
|
90.56 | 17.5% | 36.18% | 113,210.59 | 4.1% | 8.19% |
|
LSE:GSK
GSK
|
18.13 | 5.18% | 20.68% | 73,914.43 | 3.2% | 0.79% |
|
NasdaqGS:SGEN
Seattle Genetics Inc
|
228.74 | 0% | 0% | 43,154.7 | 0% | 0% |
|
NYSE:BHC
Bausch Health Companies
|
7.08 | 146.24% | 169% | 2,549.24 | 0% | -2.74% |
|
SHSE:600267
Zhejiang Hisun Pharmaceutical
|
7.87 | 0% | 0% | 13,659.27 | 1.92% | 10.59% |
|
NasdaqGM:SUPN
Supernus Pharmaceuticals
|
28.74 | 2.87% | 17.34% | 1,720.68 | 0% | -11.07% |
|
NasdaqCM:HRTX
Heron Therapeutics
|
3.00 | 0% | 0% | 442.92 | 0% | 0% |
|
NasdaqGM:URGN
UroGen Pharma
|
13.78 | 0% | 0% | 434.72 | 0% | 0% |
|
NasdaqGS:ACOR
Acorda Therapeutics
|
0.43 | 0% | 0% | 0.53 | 0% | 0% |
